Crossmark

Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies

Crossref DOI link: https://doi.org/10.1186/s12967-022-03670-7

Published Online: 2022-10-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Giampietri, Claudia

Scatozza, Francesca

Crecca, Elena

Vigiano Benedetti, Virginia

Natali, Pier Giorgio

Facchiano, Antonio https://orcid.org/0000-0002-4243-2392
Funding

Funding for this research was provided by:

Italian Ministry of Health (RC2021. Line 3.4)
License Information

Text and Data Mining valid from 2022-10-12

Version of Record valid from 2022-10-12
More Information

Article History

Received: 29 July 2022

Accepted: 25 September 2022

First Online: 12 October 2022

Declarations

:

: All data analyzed in the preset study come from public databases, therefore no ethical approval nor specific consent is necessary.

: N/A (no individual person data are reported).

: No competing interests.

Document is current

Any future updates will be listed below